Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Today, we’re diving into the frustrating world of prior authorizations. Delays, denials, and endless paperwork—this process isn’t just a headache for providers; it’s a barrier for patients who need timely care.
Joining us is Colin Banas, MD, MHA, chief medical officer at DrFirst, who willl unpack why this system is broken and how we can fix it. From shocking patient delays to the surprising role of fax machines in 2025, we’ll explore why prior auths are driving burnout, potentially harming outcomes, and what’s being done to streamline the process.
Whether you’re a provider, patient, or just curious about health care’s hidden hurdles—stick around. This is one episode you won’t want to miss.
Listen above or on one of these podcast services:
Accessibility Important After FDA Approves Lenacapavir for PrEP: Q&A With Colleen Kelley, MD, MPH
June 20th 2025The approval of lenacapavir, a form of pre-exposure prophylaxis (PrEP), marks significant progress in preventing HIV, making it vital for the treatment to be available and accessible to those most vulnerable, explains Colleen Kelley, MD, MPH, Rollins School of Public Health at Emory University.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
10 Years of Coverage Gains Threatened by Proposed Federal Policy Changes, Report Finds
June 18th 2025The country has seen historic reductions in uninsured rates and improvements in affordability since the implementation of the Affordable Care Act, the Commonwealth Fund scorecard shows.
Read More
Accessibility Important After FDA Approves Lenacapavir for PrEP: Q&A With Colleen Kelley, MD, MPH
June 20th 2025The approval of lenacapavir, a form of pre-exposure prophylaxis (PrEP), marks significant progress in preventing HIV, making it vital for the treatment to be available and accessible to those most vulnerable, explains Colleen Kelley, MD, MPH, Rollins School of Public Health at Emory University.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
10 Years of Coverage Gains Threatened by Proposed Federal Policy Changes, Report Finds
June 18th 2025The country has seen historic reductions in uninsured rates and improvements in affordability since the implementation of the Affordable Care Act, the Commonwealth Fund scorecard shows.
Read More
2 Commerce Drive
Cranbury, NJ 08512